Nupharmisto
FDA Label NDC 71331-113

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Orange Lab, Inc for the product Nupharmisto (NDC 71331-113). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding drug facts, purpose, warnings, when using this product, stop use and ask a doctor if, keep out of reach of children, how to use it correctly?, inactive ingredients, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.